K vs NRIX · P/E 23, $29.03B cap vs rev $54.5M
Kellanova (K) versus Nurix Therapeutics Inc (NRIX) — a side-by-side from cached financials, not a winner call.
Kellanova (K) is a packaged foods company listed on US.
Nurix Therapeutics Inc (NRIX) is a biotechnology company listed on NASDAQ.
K does not have a complete income-statement cache yet.
Latest reported NRIX revenue for 2024-11-30 was $54.5M. Net income was -$193.6M. Revenue was down 29.1% from 2023-11-30 to 2024-11-30. NRIX currently screens at market cap $1.77B.
K currently screens at market cap $29.03B and trailing P/E 22.8. NRIX currently screens at market cap $1.77B.
Not investment advice. Open the K and NRIX stock pages for the full models.
Not investment advice.